Centessa (CNTA) Pharmaceuticals announced that it has commenced an underwritten public offering of American Depositary Shares, ADSs, each representing one ordinary share. All of the ADSs are being offered by Centessa. Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Oppenheimer & Co., Truist Securities and LifeSci Capital are acting as co-lead managers.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa Pharmaceuticals: Promising Developments in Sleep Disorder Treatments Drive Buy Rating
- Centessa Pharmaceuticals Advances OX2R Agonist Program
- RBC says Centessa data highlights ‘impressive profile’ of Alkermes’ alixorexton
- Centessa narcolepsy data not superior to Alkermes, says Stifel
- Alkermes jumps 10% after Centessa narcolepsy data